NCT00982033View on ClinicalTrials.gov

Effects of Aliskiren on Patient With Heart Failure and a Normal Ejection Fraction

PHASE4CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

September 30, 2011

Study Completion Date

December 31, 2011

Conditions
Heart Failure
Interventions
DRUG

aliskiren

aliskiren 300mg qd versus placebo for 24 weeks.

DRUG

placebo

placebo qd for 24 weeks

Trial Locations (1)

27157

Wake Forest University Health Sciences, Winston-Salem

Sponsors

Collaborators (1)

Novartis Pharmaceuticals
All Listed Sponsors
collaborator

Novartis Pharmaceuticals

INDUSTRY

lead

Wake Forest University Health Sciences

OTHER